Japanese

Gastric Cancer Chemotherapy Based on Chemosensitivity Test Tetsuro Kubota 1 1Department of Surgery, Keio University School of Medicine Keyword: 抗癌剤感受性試験 , 標準的治療 , 胃癌 , 化学療法 pp.1023-1026
Published Date 2005/6/25
DOI https://doi.org/10.11477/mf.1403100219
  • Abstract
  • Look Inside
  • Reference

The accuracy of the chemosensitivity test in this country was 74 %(30th Annual Meeting of the Japan Research Society for Appropriate Cancer chemotherapy). Based upon the hypothesis, that appropriate adjuvant cancer chemotherapy will increase the survival outcome after surgery of advanced gastric cancer, we have clarified the usefulness of the chemosensitivity test in evaluating the appropriate adjuvant chemotherapy for gastric cancer. Since the gastric cancer cohort includes tumors respondent and non-respondent to adjuvant cancer chemotherapy, a single randomized control trial with small numbers will rarely indicate the usefulness of adjuvant cancer chemotherapy, while plural meta-analyses suggest the usefulness of adjuvant cancer chemotherapy for gastric cancer. The chemosensitivity test will be useful to differentiate the tumors respondent and non-respondent to adjuvant cancer chemotherapy, and two studies are planned to compare the assay-guided therapy and standard therapy after gastric cancer surgery.


Copyright © 2005, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1219 印刷版ISSN 0536-2180 医学書院

関連文献

もっと見る

文献を共有